NCT06877611View on ClinicalTrials.gov

A Phase 1 Study of S-4321

PHASE1RecruitingINTERVENTIONAL

Enrollment

96

Participants

Timeline

Start Date

April 3, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Healthy Volunteer

Interventions

DRUG

S-4321

S-4321 via subcutaneous or intravenous administration

OTHER

Placebo

Placebo via subcutaneous or intravenous administration.

Trial Locations (1)

Unknown

RECRUITING

Veritus Research, Bayswater

Sponsors

Collaborators (1)

Avance Clinical Pty Ltd.

All Listed Sponsors

collaborator

Avance Clinical Pty Ltd.

INDUSTRY

lead

Seismic Therapeutic AU Pty Ltd

INDUSTRY